Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:
“ASCO 2025 Abstract
Lung Cancer Poster
Unraveling relatlimab-specific biology: Biomarker analyses in pts with metastatic NSCLC treated with 1L nivolumab + RELA high-dose and chemotherapy
Martin Reck, Poster Bd7, Abstr8527″
Abstract Title: Unraveling relatlimab (RELA)-specific biology: Biomarker analyses in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) treated with 1L nivolumab (NIVO) + RELA high-dose (HD) and platinum-doublet chemotherapy (PDCT).
Authors: Martin Reck, Jaclyn Neely, Vamsidhar Velcheti, Sheida Hayati, Annie Yu, Korey Demers, Michael Schenker, Manuel Cobo, Mauricio Burotto, Francisco Orlandi, Priyanka Kasbekar, Anila Qureshi, Charlie Garnett-Benson, Nicolas Girard
Read Full Abstract on ASCO.
More Posts Featuring Hidehito Horinouchi on OncoDaily.